Parents

Sign in to add mentor
John H. Richards grad student 1977 Caltech
 (The mechanism of action of adenosylcobalamin. 3-fluoro-1, 2-propanediol dehydrase--mechanistic implications. Glycerol and other substrate analogues as substrates and inactivators for propanediol dehydrase. Kinetics, stereospecificity and mechanism. The in)
John D. Roberts post-doc 1978 Caltech
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Panaro BL, Coppage AL, Beaudry JL, et al. (2018) Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice. Molecular Metabolism
Roediger B, Lee Q, Tikoo S, et al. (2018) An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis. Cell
Okondo MC, Johnson DC, Sridharan R, et al. (2016) DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nature Chemical Biology
Coppage AL, Heard KR, DiMare MT, et al. (2016) Human FGF-21 Is a Substrate of Fibroblast Activation Protein. Plos One. 11: e0151269
Fan MH, Zhu Q, Li HH, et al. (2015) Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lung in Mice. The Journal of Biological Chemistry
Wong PF, Gall MG, Bachovchin WW, et al. (2015) Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma. Peptides
Han R, Wang X, Bachovchin W, et al. (2015) Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. Scientific Reports. 5: 12348
Tomas E, Stanojevic V, McManus K, et al. (2015) GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice. Diabetes. 64: 2409-19
Williams KH, Viera de Ribeiro AJ, Prakoso E, et al. (2015) Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Diabetes Research and Clinical Practice. 108: 466-72
Akopian T, Kandror O, Tsu C, et al. (2015) Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity. The Journal of Biological Chemistry. 290: 11008-20
See more...